Medical Discourse: Big Dreams, Small Performance – The Capital Market

The Cannabis Company

Medical Discourse
-1.5%

Medical Discourse
65.5
-1.5%

Base:66.5

opening:67.9

High:69.5

low:63.8

change:935,568

Page Quote News Graphs Company Profile Recommendations


More articles on the subject:




Trading at a value of NIS 225 million, reports revenues of NIS 36.8 million in 2020 – an increase of 28% compared to the previous year. The increase in revenue is due to growth in business activity and a shift to sales under the new regulation. However, revenues during the year fluctuated between quarters (second quarter NIS 11.5 million, third quarter NIS 6.6 million and fourth quarter back to NIS 11 million). Beyond that, growth of 28% per year is not a big deal for an area that is considered very growing. Maybe the dreams of exporting cannabis were too big. After all, in Canada and the United States there are cannabis powers that sell around the world goods that are perceived as very high quality in the amount of hundreds of millions of dollars.

and yet – Discourse estimates that the export trend to the countries in which the company currently operates, which began in the last quarter of 2020, as well as other countries, will continue and lead to a further increase in revenues during 2021.

The net profit in 2020 was NIS 12.0 million, but this is a profit that includes revaluations of securities. In practice the profit is half of that.

Adjusted profit In 2020 (profit without the effect of changes in the fair value of a biological asset, share-based payment and listing expenses for trading) amounted to NIS 18.1 million, compared with NIS 9.3 million in 2019. However, given the securities earnings / revaluation gains, this is a low profit More.

Sheikh Medical Group Chairman Nir Zichlinsky said: “In 2021 we will work to adopt ESG policy as part of the discourse company’s values ​​for environmental protection, sustainability, and corporate governance. In the current periodic report, we paid attention to the field of corporate governance and reported using the questionnaire of the Securities Authority on the subject, although we are not obligated to report as such. As of the balance sheet date, the discourse has significant financial strength and a cash balance of NIS 25.5 million, which allows us to look for strategic acquisitions that are synergistic with the company’s operations. ”